Cartalax (20mg)

Login to view prices.

Existing research has found the following:

Supports Cartilage & Joint Integrity Research – Studied for its potential to influence cartilage maintenance, chondrocyte activity, and overall connective-tissue stability in experimental models.

Explores Connective-Tissue Regeneration Mechanisms – Investigated for its role in collagen organization, extracellular-matrix signaling, and cartilage-repair pathways.

Evaluates Inflammation & Degenerative-Joint Models – Examined for its involvement in modulating inflammatory stress, cytokine activity, and cartilage-degradation processes.

Supports Structural Resilience & Mobility Research – Studied for its potential to enhance joint durability, shock absorption, and movement-related tissue performance in pre-clinical systems.

Description

Cartilage-Matrix and Connective-Tissue Research

Cartalax is a short-chain peptide bioregulator studied in pre-clinical and cellular models for its potential influence on cartilage-matrix maintenance, chondrocyte activity, and connective-tissue integrity.

Joint-Structure and Mobility Models

Experimental research has explored Cartalax for its role in supporting cartilage homeostasis, making it useful in models focused on joint resilience, movement quality, and age-related connective-tissue decline.

Chondrocyte-Regeneration Research

Cartalax has been investigated for its ability to influence chondrocyte function and extracellular-matrix signaling, providing a foundation for studying cartilage repair, regeneration, and tissue remodeling pathways.

Inflammation and Degenerative-Joint Models

Laboratory data suggest Cartalax may be relevant in research involving inflammatory stress, cartilage breakdown, and degenerative joint conditions, especially where cytokine activity and matrix degradation are being evaluated.

Collagen and Proteoglycan-Synthesis Studies

Cartalax may support investigations into collagen organization, proteoglycan balance, and structural cartilage components that contribute to tissue strength, elasticity, and shock absorption.

Age-Related Connective-Tissue Research

Because cartilage and connective tissue naturally decline with age, Cartalax is commonly studied in longevity-focused models examining tissue preservation, joint function, and structural resilience over time.

Recovery and Tissue-Remodeling Models

Cartalax may be useful in experimental settings evaluating post-stress connective-tissue recovery, cartilage adaptation, and biological repair mechanisms following mechanical or inflammatory strain.

STORAGE DETAILS

Lyophilized Cartalax is typically stored sealed, protected from heat, light, and moisture. For long-term stability, refrigeration is recommended. After reconstitution, refrigerate and use according to validated research-handling protocols.

Product Specifications

Application: Research peptide with potential in cartilage, joint, and connective-tissue studies

Appearance: Solid, white lyophilized powder in 3mL glass vial

Synonyms: Cartalax, cartilage peptide bioregulator

Storage: Store refrigerated, sealed, away from heat, light, and moisture.

Concentration: ≥98%

Research Use Only (RUO). Not for human or animal use. Not for diagnostic, therapeutic, or clinical applications. No claims are made regarding joint repair, pain relief, cartilage regeneration, or mobility improvement in humans. End-user assumes responsibility for determining suitability for specific research protocols.